Annular Rupture During Transcatheter Aortic Valve Implantation: Predictors, Management and Outcomes.
KeywordsTranscatheter aortic valve implantation (TAVI)
aortic annular rupture
balloon aortic valvuloplasty (BAV)
multislice computed tomography (MSCT)
transcatheter heart valve (THV)
transoesophageal echocardiography (TEE)
transthoracic echocardiography (TTE)
MetadataShow full item record
PublisherInternational Cardiology Review
JournalInternational Cardiology Review
AbstractTranscatheter aortic valve implantation (TAVI) is the treatment of choice in patients with symptomatic severe aortic stenosis who are either inoperable or at high risk for conventional surgical aortic valve replacement. Recent data have also shown favourable outcomes in patients deemed to be at intermediate operative risk, which expands the application of this novel technology. Despite its success, TAVI has been associated with rare life-threatening complications. Of these, aortic annular rupture is considered to be the most devastating. Advances in pre-procedural screening and patient selection have reduced the incidence of annular rupture. When this complication occurs, early recognition and prompt management are essential. This article is intended to provide a comprehensive review of the predictors, management and clinical outcomes of aortic annular rupture.
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States
- [Comparison of aortic annular diameter defined by different measurement mordalities before transcatheter aortic valve implantation].
- Authors: Qi RX, You XD, Pu ZX, Yang Q, Huang ZX, Zhou LM, Huang PT
- Issue date: 2017 May 24
- First experience with transfemoral transcatheter aortic valve implantation without prior balloon pre-dilatation using a latest generation repositionable and retrievable transcatheter heart valve†.
- Authors: Schaefer A, Harmel E, Seiffert M, Reichart D, Deuschl F, Schofer N, Schneeberger Y, Blankenberg S, Reichenspurner H, Schaefer U, Conradi L
- Issue date: 2017 May 1
- [Management of non-rhythmic complications of TAVI procedures].
- Authors: Nejjari M, Cacoub L, Digne F
- Issue date: 2019 Dec
- Prosthesis sizing for transcatheter aortic valve implantation--comparison of three dimensional transesophageal echocardiography with multislice computed tomography.
- Authors: Husser O, Holzamer A, Resch M, Endemann DH, Nunez J, Bodi V, Schmid C, Riegger GA, Gössmann H, Hamer O, Stroszczynski C, Luchner A, Hilker M, Hengstenberg C
- Issue date: 2013 Oct 9
- The role of echocardiography in transcatheter aortic valve implantation.
- Authors: Onishi T, Sengoku K, Ichibori Y, Mizote I, Maeda K, Kuratani T, Sawa Y, Sakata Y
- Issue date: 2018 Feb
Showing items related by title, author, creator and subject.
Acute aortic occlusion in a patient with heparin-induced thrombocytopenia treated by thrombectomy.Collins, D; Moloney, M A; O'Donnell, D; Brophy, D; Sheehan, S J; Department of Vascular Surgery, St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland. email@example.com (2012-09)Heparin-induced thrombocytopenia syndrome (HITS) is an infrequent complication of heparin anticoagulation.
The need for intra aortic balloon pump support following open heart surgery: risk analysis and outcome.Parissis, Haralabos; Leotsinidis, Michael; Akbar, Mohammad Tauqeer; Apostolakis, Efstratios; Dougenis, Dimitrios; Royal Victoria Hospital, Cardiothoracic Department, Belfast, Nothern Ireland. firstname.lastname@example.org (2010)BACKGROUND: The early and intermediate outcome of patients requiring intraaortic balloon pump (IABP) was studied in a cohort of 2697 adult cardiac surgical patients. METHODS: 136 patients requiring IABP (5.04%) support analysed over a 4 year period. Prospective data collection, obtained. RESULTS: The overall operative mortality was 35.3%. The "operation specific" mortality was higher on the Valve population.The mortality (%) as per time of balloon insertion was: Preoperative 18.2, Intraoperative 33.3, postoperative 58.3 (p < 0.05).The incremental risk factors for death were: Female gender (Odds Ratio (OR) = 3.87 with Confidence Intervals (CI) = 1.3-11.6), Smoking (OR = 4.88, CI = 1.23- 19.37), Preoperative Creatinine>120 (OR = 3.3, CI = 1.14-9.7), Cross Clamp time>80 min (OR = 4.16, CI = 1.73-9.98) and IABP insertion postoperatively (OR = 19.19, CI = 3.16-116.47).The incremental risk factors for the development of complications were: Poor EF (OR = 3.16, CI = 0.87-11.52), Euroscore >7 (OR = 2.99, CI = 1.14-7.88), history of PVD (OR = 4.99, CI = 1.32-18.86).The 5 years survival was 79.2% for the CABG population and 71.5% for the valve group. (Hazard ratio = 1.78, CI = 0.92-3.46). CONCLUSIONS: IABP represents a safe option of supporting the failing heart. The need for IABP especially in a high risk Valve population is associated with early unfavourable outcome, however the positive mid term results further justify its use.
Endovascular stent graft treatment of acute thoracic aortic transections due to blunt force trauma.Bjurlin, Marc A; Tanquilut, Eugene M; Subram, Aswath; Kalkounos, Peggy; Merlotti, Gary J; Division of Trauma, St. James Hospital and Health Centers, Midwestern University,, Olympia Fields, Illinois, USA. (2012-02-01)Endovascular stent graft treatment of acute thoracic aortic transections is an encouraging minimally invasive alternative to open surgical repair. Between 2006 and 2008, 16 patients with acute thoracic aortic transections underwent evaluation at our institution. Seven patients who were treated with an endovascular stent graft were reviewed. The mean Glasgow Coma Score was 13.0, probability of survival was .89, and median injury severity score was 32. The mean number of intensive care unit days was 7.7, mean number of ventilator support days was 5.4, and hospital length of stay was 10 days. Mean blood loss was 285 mL, and operative time was 143 minutes. Overall mortality was 14%. Procedure complications were a bleeding arteriotomy site and an endoleak. Endovascular treatment of traumatic thoracic aortic transections appears to demonstrate superior results with respect to mortality, blood loss, operative time, paraplegia, and procedure-related complications when compared with open surgical repair literature.